Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | CCR5 |
| Upstream (Parents) |
|---|
| (<<) HLA-DQA2///HLA-DQA1 → CCR5 |
| (<<) HLA-DPB1 → CCR5 |
| (<<) ITGB2 → CCR5 |
| (<<) CD86 → CCR5 |
| Downstream (Children) |
|---|
| CCR5 → RGS13 (>>) |
| CCR5 → CD1E (>>) |
| CCR5 → CCR7 (>>) |
| CCR5 → LTK (>>) |
| CCR5 → GAGE3 (>>) |
| CCR5 → ATP2B3 (>>) |
| CCR5 → KEL (>>) |
| CCR5 → EXOSC2 (>>) |
| CCR5 → SOAT1 (>>) |
